GSK to pay up to $3.3 billion for biopharma Affinivax By: MarketWatch May 31, 2022 at 04:50 AM EDT GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc. for up to $3.3 billion. Read More >> Related Stocks: Gsk Plc ADR
